BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35033585)

  • 1. The NF-κB-Regulated miR-221/222/Syndecan-1 Axis and Intestinal Mucosal Barrier Function in Radiation Enteritis.
    Wang Z; Wang Q; Gong L; Liu T; Wang P; Yuan Z; Wang W
    Int J Radiat Oncol Biol Phys; 2022 May; 113(1):166-176. PubMed ID: 35033585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-1 Acts in Synergy with Tight Junction Through Stat3 Signaling to Maintain Intestinal Mucosal Barrier and Prevent Bacterial Translocation.
    Wang Z; Li R; Tan J; Peng L; Wang P; Liu J; Xiong H; Jiang B; Chen Y
    Inflamm Bowel Dis; 2015 Aug; 21(8):1894-907. PubMed ID: 25970544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of miR-155 alleviates sepsis-induced inflammation and intestinal barrier dysfunction by inactivating NF-κB signaling.
    Cao YY; Wang Z; Wang ZH; Jiang XG; Lu WH
    Int Immunopharmacol; 2021 Jan; 90():107218. PubMed ID: 33296782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression.
    Qing Q; Zhang S; Chen Y; Li R; Mao H; Chen Q
    J Cell Mol Med; 2015 Jun; 19(6):1366-74. PubMed ID: 25702768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-delivered syndecan-1 rescues acute lung injury via a FAK/p190RhoGAP/RhoA/ROCK/NF-κB signaling axis and glycocalyx enhancement.
    Zhang C; Guo F; Chang M; Zhou Z; Yi L; Gao C; Huang X; Huan J
    Exp Cell Res; 2019 Nov; 384(1):111596. PubMed ID: 31487506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa-miR-375 promotes the progression of inflammatory bowel disease by upregulating TLR4.
    Wu CP; Bi YJ; Liu DM; Wang LY
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7543-7549. PubMed ID: 31539144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis.
    Zhang Y; Wang Z; Liu J; Zhang S; Fei J; Li J; Zhang T; Wang J; Park PW; Chen Y
    J Cell Mol Med; 2017 Jan; 21(1):13-25. PubMed ID: 27558380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of down-regulated microRNA-31 on intestinal barrier dysfunction through inhibition of NF-κB/HIF-1α pathway by binding to HMOX1 in rats with sepsis.
    Zhan CY; Chen D; Luo JL; Shi YH; Zhang YP
    Mol Med; 2018 Oct; 24(1):55. PubMed ID: 30340459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways.
    Lei Q; Qiang F; Chao D; Di W; Guoqian Z; Bo Y; Lina Y
    Int J Mol Med; 2014 Dec; 34(6):1629-39. PubMed ID: 25318952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of high mobility group box 1 in intestinal mucosal barrier injury in rat with sepsis induced by endotoxin].
    Chen S; Xiu G; Zhou J; Liu P; Chen X; Sun J; Ling B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jul; 32(7):803-807. PubMed ID: 32788013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
    Ye X; Sun M
    Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function.
    Nata T; Fujiya M; Ueno N; Moriichi K; Konishi H; Tanabe H; Ohtake T; Ikuta K; Kohgo Y
    J Gene Med; 2013; 15(6-7):249-60. PubMed ID: 23813877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-
    Guo S; Chen S; Ma J; Ma Y; Zhu J; Ma Y; Liu Y; Wang P; Pan Y
    Mediators Inflamm; 2019; 2019():5796491. PubMed ID: 31354386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-34c and PlncRNA1 mediated the function of intestinal epithelial barrier by regulating tight junction proteins in inflammatory bowel disease.
    Chen T; Xue H; Lin R; Huang Z
    Biochem Biophys Res Commun; 2017 Apr; 486(1):6-13. PubMed ID: 28153728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Intestinal Barrier Function in Sepsis by Partially Hydrolysed Guar Gum via the Suppression of the NF-κB/MLCK Pathway.
    Tang Z; Zhu Y; Hu X; Lui K; Li S; Song X; Cai C; Guan X
    Mol Biotechnol; 2024 May; ():. PubMed ID: 38789715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenectomy attenuates severe thermal trauma-induced intestinal barrier breakdown in rats.
    Liu XD; Chen ZY; Yang P; Huang WG; Jiang CF
    J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):868-873. PubMed ID: 26670438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0114427 promotes LPS-induced septic acute kidney injury by modulating miR-495-3p/TRAF6 through the NF-κB pathway.
    Xu L; Cao H; Xu P; Nie M; Zhao C
    Autoimmunity; 2022 Feb; 55(1):52-64. PubMed ID: 34730059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary leonurine hydrochloride supplementation attenuates lipopolysaccharide challenge-induced intestinal inflammation and barrier dysfunction by inhibiting the NF-κB/MAPK signaling pathway in broilers.
    Yang L; Liu G; Lian K; Qiao Y; Zhang B; Zhu X; Luo Y; Shang Y; Gu XL
    J Anim Sci; 2019 Apr; 97(4):1679-1692. PubMed ID: 30789669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective Effect of Kaempferol on LPS-Induced Inflammation and Barrier Dysfunction in a Coculture Model of Intestinal Epithelial Cells and Intestinal Microvascular Endothelial Cells.
    Bian Y; Dong Y; Sun J; Sun M; Hou Q; Lai Y; Zhang B
    J Agric Food Chem; 2020 Jan; 68(1):160-167. PubMed ID: 31825618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells.
    Asuthkar S; Velpula KK; Nalla AK; Gogineni VR; Gondi CS; Rao JS
    Oncogene; 2014 Apr; 33(15):1922-33. PubMed ID: 23728345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.